Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2020

View Archived Issues

If a tree stings in the wood, it's with a peptide

XBiotech is developing Fluvid as novel treatment for influenza and COVID-19 coinfections

Nocion Therapeutics presents new SCN9A blockers

Roche synthesizes new antibacterial compounds

FronThera US Pharmaceuticals discloses TYK2 inhibitors

Genhouse Medicine identifies PTPN11 inhibitors

FDA clears IND for phase I trial of Emmecell's EO-2002 for corneal edema

Arthritis is different disease with antibodies than without

First data for the anti-CD73 oleclumab in triple-negative breast cancer

Results presented for ipatasertib plus abiraterone in mCRPC

Vaccination with a centrin KO Leishmania major strain is safe, immunogenic and disease-protective

Circulating DPP3 inhibition restores cardiac function during sepsis in CLP rat models

Japanese phase III study of Avigan shows promise in patients with COVID-19

First healthy volunteers dosed in phase I study of MORF-057

FDA allows IND application for TCRT-ESO-A2

Cytokinetics initiates phase I study of CK-3772271

Using tumor organoids, researchers identify recurrent, druggable neuroblastoma targets

MIL-62 demonstrates promising safety and efficacy in CD20-positive B-cell NHL

Janssen's COVID-19 vaccine candidate JNJ-78436735 enters phase III

Ensifentrine enters phase III trials for moderate to severe COPD

Millendo begins first-in-human study of MLE-301 for vasomotor symptoms in menopausal women

First-in-human data reported for MGD-019

Phase I data on NMT-cP12 support progression to phase II for severe burns

Japanese approval for Jyseleca in rheumatoid arthritis

Genfit begins phase III study of elafibranor in primary biliary cholangitis

Phase II study of semorinemab in early Alzheimer's misses key efficacy endpoints

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...